Pfizer: 2026 Guidance Points To Continued Margin And Growth Pressure [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
PFE's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 both decline year-over-year, reflecting persisting headwinds. Capital allocation remains constrained with long-term debt elevated, share repurchases halted, and share count slightly diluted. Ongoing strategic shift is unlikely to translate into tangible financial improvements in the near term and/or share price performance. Looking for a helping hand in the market? Members of Envision Early Retirement get exclusive ideas and guidance to navigate any climate. Learn More » ProArtWork/iStock Unreleased via Getty Images Pfizer's Full-Year 2026 Financial Guidance I last covered Pfizer Inc. stock ( PFE ) on Nov 8, 2025, with an article titled "Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer". The article mainly served as a This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such posi
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- GSK to buy RAPT Therapeutics in $2.2 billion deal for promising food allergy therapy [Yahoo! Finance]Yahoo! Finance
- Down 55%, Should You Buy the Dip on Pfizer? [Yahoo! Finance]Yahoo! Finance
- MoneyShow's Best Investment Ideas For 2026: Part 7 [Seeking Alpha]Seeking Alpha
- Could Pfizer Inc.'s (NYSE:PFE) Weak Financials Mean That The Market Could Correct Its Share Price? [Yahoo! Finance]Yahoo! Finance
- Pfizer (PFE) CEO Isn't Ready For A Fight With RFK Jr., Says Jim Cramer [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 1/16/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- PFE's page on the SEC website